Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
Novel cerebrospinal fluid and serum autoantibody targets for Clinically Isolated Syndrome.
What do multiple sclerosis patients and their caregivers perceive as unmet needs?
Phagocytosis of Microglia in the Central Nervous System Diseases.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Mutation Update of ARSA and PSAP genes causing Metachromatic Leukodystrophy.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
JAML mediates monocyte and CD8 T cell migration across the brain endothelium.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
The Roles of Egr-2 in Autoimmune Diseases.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Inefficient clearance of myelin debris by microglia impairs remyelinating processes.
Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.
Your client has multiple sclerosis: understanding the challenge.
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
[Adaptative immunity and pathophysiology of multiple sclerosis.]
Impaired social cognition in multiple sclerosis.
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
An observational study of venoplasty in patients with multiple sclerosis.
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Glucocorticoid treatment of multiple sclerosis.
MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination.
JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »